Neurofeedback Intervention in Fibromyalgia Syndrome; a Randomized, Controlled, Rater Blind Clinical Trial

Abstract

We designed a randomized, rater blind study to assess the efficacy of EEG Biofeedback (Neurofeedback-NFB) in patients with fibromyalgia syndrome (FMS). Eighteen patients received twenty sessions of NFB-sensory motor rhythm (SMR) treatment (NFB group) during 4 weeks, and eighteen patients were given 10 mg per day escitalopram treatment (control group) for 8 weeks. Visual Analog Scales for pain and fatigue, Hamilton and Beck Depression and Anxiety Inventory Scales, Fibromyalgia Impact Questionnaire and Short Form 36 were used as outcome measures which were applied at baseline and 2nd, 4th, 8th, 16th, 24th weeks. Mean amplitudes of EEG rhythms (delta, theta, alpha, SMR, beta1 and beta2) and theta/SMR ratio were also measured in NFB group. All post-treatment measurements showed significant improvements in both of the groups (for all parameters p < 0.05). NFB group displayed greater benefits than controls (for all parameters p < 0.05). Therapeutic efficacy of NFB was found to begin at 2nd week and reached to a maximum effect at 4th week. On the other hand, the improvements in SSRI treatment were also detected to begin at 2nd week but reached to a maximum effect at 8th week. No statistically significant changes were noted regarding mean amplitudes of EEG rhythms (p > 0.05 for all). However, theta/SMR ratio showed a significant decrease at 4th week compared to baseline in the NFB group (p < 0.05). These data support the efficacy of NFB as a treatment for pain, psychological symptoms and impaired quality of life associated with fibromyalgia.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. Ahles, T. A., Khan, S. A., Yunus, M. B., Spiegel, D. A., & Masi, A. T. (1991). Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: A blind comparison of DSM-III diagnoses. The American Journal of Psychiatry, 148, 1721–1726.

    PubMed  Google Scholar 

  2. Akdemir, A., Türkçapar, M. H., Orsel, S. D., Demirergi, N., Dag, I., & Ozbay, M. H. (2001). Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Comprehensive Psychiatry, 42(2), 161–165.

    Article  PubMed  Google Scholar 

  3. Alanoglu, E., Ulas, U. H., Ozdag, F., Odabaşi, Z., Cakçi, A., & Vural, O. (2005). Auditory event-related brain potentials in fibromyalgia syndrome. Rheumatology International, 25(5), 345–349.

    Article  PubMed  Google Scholar 

  4. Anderberg, U. M., Marteinsdottir, I., & von Knorring, L. (2000). Citalopram in patients with fibromyalgia—a randomized, double-blind, placebo-controlled study. European Journal of Pain, 4(1), 27–35.

    Article  PubMed  Google Scholar 

  5. Babu, A. S., Mathew, E., Danda, D., & Prakash, H. (2007). Management of patients with fibromyalgia using biofeedback: A randomized control trial. Indian Journal of Medical Sciences, 61(8), 455–461.

    Article  PubMed  Google Scholar 

  6. Basmajian, J. V. (1982). Clinical use of biofeedback in rehabilitation. Psychosomatics, 23, 67–73.

    PubMed  Google Scholar 

  7. Bennett, R. M. (1999). Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia (review). Mayo Clinic Proceedings, 74, 385–398.

    Article  PubMed  Google Scholar 

  8. Caruso, I., Sarzi Puttini, P., Cazzola, M., & Azzolini, V. (1990). Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. The Journal of International Medical Research, 18(3), 201–209.

    PubMed  Google Scholar 

  9. Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., et al. (2008). EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases, 67, 536–541.

    Article  PubMed  Google Scholar 

  10. Chiarioni, G., Salandini, L., & Whitehead, W. E. (2005). Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology, 129(1), 86–97.

    Article  PubMed  Google Scholar 

  11. Çorapçıoğlu, A., Aydemir, Ö., Yıldız, M., Esen, A., & Köroğlu, E. (1999). DSM-IV Eksen-I Bozuklukları İçin Yapılandırılmış Klinik Görüşme. Ankara, Turkey: Hekimler Yayın Birliği.

    Google Scholar 

  12. Crider, A., Glaros, A. G., & Gevirtz, R. N. (2005). Efficacy of biofeedback-based treatments for temporomandibular disorders. Applied Psychophysiology and Biofeedback, 30(4), 333–345.

    Article  PubMed  Google Scholar 

  13. Da Costa, D., Dobkin, P. L., Fitzcharles, M. A., Fortin, P. R., Beaulieu, A., Zummer, M., et al. (2000). Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus. The Journal of Rheumatology, 27(2), 365–372.

    PubMed  Google Scholar 

  14. Denk, D. M., & Kaider, A. (1997). Videoendoscopic biofeedback: a simple method to improve the efficacy of swallowing rehabilitation of patients after head and neck surgery. Journal for Oto-Rhino-Laryngology and Its Related Specialties, 59(2), 100–105.

    PubMed  Google Scholar 

  15. Draizar, A. (1984). Clinical EMG feedback in motor speech disorders. Archives of Physical Medicine and Rehabilitation, 65(8), 481–484.

    PubMed  Google Scholar 

  16. Dursun, E. (2009). Biofeedback. In J. H. Stone, M. Blouin (Eds.), International encyclopedia of rehabilitation. http://cirrie.buffalo.edu/encyclopedia/article.php?id=23&language=en.

  17. Dursun, E., Dursun, N., & Alican, D. (2004). Effects of biofeedback treatment on gait in children with cerebral palsy. Disability and Rehabilitation, 26(2), 116–120.

    Article  PubMed  Google Scholar 

  18. Dursun, N., Dursun, E., & Kiliç, Z. (2001). Electromyographic biofeedback-controlled exercise versus conservative care for patellofemoral pain syndrome. Archives of Physical Medicine and Rehabilitation, 82(12), 1692–1695.

    Article  PubMed  Google Scholar 

  19. Egner, T., & Gruzelier, J. H. (2001). Learned self-regulation of EEG frequency components affects attention and event-related brain potentials in humans. Neuroreport, 12, 4155–4160.

    Article  PubMed  Google Scholar 

  20. Egner, T., & Gruzelier, J. H. (2004). EEG biofeedback of low beta band components: frequency-specific effects on variables of attention and event-related brain potentials. Clinical Neurophysiology, 115(1), 131–139.

    Article  PubMed  Google Scholar 

  21. Egner, T., Zech, T. F., & Gruzelier, J. H. (2004). The effects of neurofeedback training on the spectral topography of the electroencephalogram. Clinical Neurophysiology, 115, 2452–2460.

    Article  PubMed  Google Scholar 

  22. Gentil, M., Aucouturier, J. L., Delong, V., & Sambuis, E. (1994). EMG biofeedback in the treatment of dysarthria. Folia Phoniatrica et Logopaedica, 46(4), 188–192.

    Article  PubMed  Google Scholar 

  23. Grace, G. M., Nielson, W. R., Hopkins, M., & Berg, M. A. (1999). Concentration and memory deficits in patients with fibromyalgia syndrome. Journal of Clinical and Experimental Neuropsychology, 21, 477–487.

    Article  PubMed  Google Scholar 

  24. Gracely, R. H., Petzke, F., Wolf, J. M., & Clauw, D. J. (2002). Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis and Rheumatism, 46, 1333–1343.

    Article  PubMed  Google Scholar 

  25. Guedj, E., Cammilleri, S., Colavolpe, C., De Laforte, C., Niboyet, J., & Mundler, O. (2007). Follow-up of pain processing recover after ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT. European Journal of Nuclear Medicine and Molecular Imaging, 34, 2115–2119.

    Article  PubMed  Google Scholar 

  26. Hidalgo, J., Rico-Villademoros, F., & Calandre, E. P. (2007). An open-label study of quetiapine in the treatment of fibromyalgia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31(1), 71–77.

    Article  PubMed  Google Scholar 

  27. Hisli, N. (1989). Beck Depresyon Envanterinin üniversite öğrencileri için geçerliliği, güvenilirliği. Psikoloji Dergisi, 7, 3–13.

    Google Scholar 

  28. Ho, Y. H., & Tan, M. (1997). Biofeedback therapy for bowel dysfunction following low anterior resection. Annals of the Academy of Medicine, Singapore, 26(3), 299–302.

    PubMed  Google Scholar 

  29. Howe, R. C., & Sterman, M. B. (1972). Cortical-subcortical EEG correlates of suppressed motor behavior during sleep and waking in the cat. Electroencephalography and Clinical Neurophysiology, 32(6), 681–695.

    Article  PubMed  Google Scholar 

  30. Intiso, D., Santilli, V., Grasso, M. G., Rossi, R., & Caruso, I. (1994). Rehabilitation of walking with electromyographic biofeedback in foot-drop after stroke. Stroke, 25(6), 1189–1192.

    PubMed  Google Scholar 

  31. Jensen, M. P., Grierson, C., Tracy-Smith, V., Bacigalupi, S. C., & Othmer, S. (2007). Neurofeedback treatment for pain associated with complex regional pain syndrome type I: A case series. Journal of Neurotherapy, 11, 45–53.

    Article  Google Scholar 

  32. Jensen, M. P., Hakimian, S., Sherlin, L. H., & Frengi, F. (2008). New insights into neuromodulatory approaches for the treatment of pain. The Journal of Pain: official journal of the American Pain Society, 9(3), 193–199.

    Google Scholar 

  33. Kayıran, S., Dursun, E., Ermutlu, N., Dursun, N., & Karamürsel, S. (2007). Neurofeedback in fibromyalgia syndrome. Ağrı, 19(3), 47–53.

    PubMed  Google Scholar 

  34. Koçyiğit, H., Aydemir, Ö., Ölmez, N., & Memiş, A. (1999). SF-36’nın Türkçe için güvenilirliği ve geçerliliği. Ege Fizik Tedavi ve Rehabilitasyon Dergisi.

  35. Kop, W. J., Lyden, A., Berlin, A. A., Ambrose, K., Olsen, C., Gracely, R. H., et al. (2005). Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis and Rheumatism, 52(1), 296–303.

    Article  PubMed  Google Scholar 

  36. Lautenbacher, S., & Rollman, G. B. (1997). Possible deficiencies of pain modulation in fibromyalgia. The Clinical Journal of Pain, 13, 189–196.

    Article  PubMed  Google Scholar 

  37. Lubar, J. F. (1997). Neocortical dynamics: Implications for understanding the role of neurofeedback and related techniques for the enhancement of attention. Applied Psychophysiology and Biofeedback, 22(2), 111–126.

    Article  PubMed  Google Scholar 

  38. Matsutani, L. A., Marques, A. P., Ferreira, E. A., Assumpção, A., Lage, L. V., Casarotto, R. A., et al. (2007). Effectiveness of muscle stretching exercises with and without laser therapy at tender points for patients with fibromyalgia. Clinical and Experimental Rheumatology, 25(3), 410–415.

    PubMed  Google Scholar 

  39. Middaugh, S. J., Whitehead, W. E., Burgio, K. L., & Engel, B. T. (1989). Biofeedback in treatment of urinary incontinence in stroke patients. Biofeedback and Self-Regulation, 14(1), 3–19.

    Article  PubMed  Google Scholar 

  40. Moldofsky, H., & Warsh, J. J. (1978). Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”). Pain, 5(1), 65–71.

    Article  PubMed  Google Scholar 

  41. Monastra, V. J., Monastra, D. M., & George, S. (2002). The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 27(4), 231–249.

    Article  PubMed  Google Scholar 

  42. Mountz, J. M., Bradley, L. A., Model, J. G., Alexander, R. W., Triana-Alexander, M., Aaron, L. A., et al. (1995). Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis and Rheumatism, 38, 926–938.

    Article  PubMed  Google Scholar 

  43. Mueller, H. H., Donaldson, C. C., Nelson, D. V., & Layman, M. (2001). Treatment of fibromyalgia incorporating EEG-Driven stimulation: A clinical outcomes study. Journal of Clinical Psychology, 57(7), 933–952.

    Article  PubMed  Google Scholar 

  44. Mur, E., Drexler, A., Gruber, J., Hartig, F., & Günther, V. (1999). Electromyography biofeedback therapy in fibromyalgia. Wiener Medizinische Wochenschrift, 149, 561–563.

    PubMed  Google Scholar 

  45. Nash, J., Neilson, P. D., & O’Dwyer, N. J. (1989). Reducing spasticity to control muscle contracture of children with cerebral palsy. Developmental Medicine and Child Neurology, 31(4), 471–480.

    Article  PubMed  Google Scholar 

  46. Othmer, S., & Othmer, S. F. (2006). Efficacy of neurofeedback for pain management. In M. V. Boswell & B. E. Cole (Eds.), Weiner’s pain management: A practical guide for clinicians (7th ed., pp. 719–739). Boca Raton: CRC Press.

    Google Scholar 

  47. Ozgocmen, S., Cimen, O. B., & Ardıcoglu, O. (2002). Relationship between chest expansion and respiratory muscle strength in patients with primary fibromyalgia. Clinical Rheumatology, 21, 19–22.

    Article  PubMed  Google Scholar 

  48. Ozgocmen, S., Yoldas, T., Kamanlı, A., Yildizhan, H., Yigiter, R., & Ardicoglu, O. (2003). Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia. Annals of the Rheumatic Diseases, 62, 551–555.

    Article  PubMed  Google Scholar 

  49. Park, D. C., Glass, J. M., Minear, M., & Crofford, L. J. (2001). Cognitive function in fibromyalgia patients. Arthritis and Rheumatism, 44, 2125–2133.

    Article  PubMed  Google Scholar 

  50. Petrofsky, J. S. (2001). The use of electromyogram biofeedback to reduce Trendelenburg gait. European Journal of Applied Physiology, 85(5), 491–495.

    Article  PubMed  Google Scholar 

  51. Pillemer, S. R., Bradley, L. A., Crofford, L. J., Moldofsky, H., & Chrousos, G. P. (1997). The neuroscience and endocrinology of fibromyalgia. Arthritis and Rheumatism, 40, 1928–1939.

    Article  PubMed  Google Scholar 

  52. Reddy, N. P., Simcox, D. L., Gupta, V., Motta, G. E., Coppenger, J., Das, A., et al. (2000). Biofeedback therapy using accelerometry for treating dysphagic patients with poor laryngeal elevation: case studies. Journal of Rehabilitation Research and Development, 37(3), 361–372.

    PubMed  Google Scholar 

  53. Reiner, R. (2008). Integrating a portable biofeedback device into clinical practice for patients with anxiety disorders: Results of a pilot study. Applied Psychophysiology and Biofeedback, 33(1), 55–61.

    Article  PubMed  Google Scholar 

  54. Rice, K. M., Blanchard, E. B., & Purcell, M. (1993). Biofeedback treatments of generalized anxiety disorder: Preliminary results. Biofeedback and Self-Regulation, 18(2), 93–105.

    Article  PubMed  Google Scholar 

  55. Ros, T., Munneke, M. A. M., Ruge, D., Gruzelier, J. H., & Rothwell, J. C. (2010). Endogenous control of waking brain rhythms induces neuroplasticity in humans. European Journal of Neuroscience, 31, 770–778.

    Article  PubMed  Google Scholar 

  56. Russell, I. J., Michalek, J. E., Vipraio, G. A., Fletcher, E. M., & Wall, K. (1989). Serum amino acids in fibrositis/fibromyalgia syndrome. The Journal of Rheumatology, 19, 158–163.

    PubMed  Google Scholar 

  57. Sarmer, S., Ergin, S., & Yavuzer, G. (2000). The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatology International, 20(1), 9–12.

    Article  PubMed  Google Scholar 

  58. Sarzi Puttini, P., & Caruso, I. (1992). Primary fibromyalgia syndrome and 5-hydroxy-l-tryptophan: A 90-day open study. The Journal of International Medical Research, 20(2), 182–189.

    PubMed  Google Scholar 

  59. Siniatchkin, M., Hierundar, A., Kropp, P., Kuhnert, R., Gerber, W. D., & Stephani, U. (2000). Self-regulation of slow cortical potentials in children with migraine: an exploratory study. Applied Psychophysiology and Biofeedback, 25(1), 13–32.

    Article  PubMed  Google Scholar 

  60. Staud, R., Vierck, C. J., Cannon, R. L., Mauderli, A. P., & Price, D. D. (2001). Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain, 91, 165–175.

    Article  PubMed  Google Scholar 

  61. Sterman, M. B. (1996). Physiological origins and functional correlates of EEG rhythmic activities: Implications for self-regulation. Biofeedback and Self-Regulation, 21(1), 3–33.

    Article  PubMed  Google Scholar 

  62. Sterman, M. B. (2000). Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning. Clinical EEG (Electroencephalography), 31, 45–55.

    Google Scholar 

  63. Strombeck, B., Ekdahl, C., Manthorpe, R., Wikström, I., & Jacobsson, L. (2000). Health-related quality of life in primary Sjogren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scandinavian Journal of Rheumatology, 29, 20–28.

    Article  PubMed  Google Scholar 

  64. Suhr, J. A. (1999). Neuropsychological impairment in fibromyalgia. Relation to depression, fatigue, and pain. Journal of Psychosomatic Research, 47, 403–410.

    Article  Google Scholar 

  65. Tomberg, C., & Desmedt, J. E. (1998). Human perceptual processing: inhibition of transient prefrontal-parietal 40 Hz binding at P300 onset documented in non-averaged cognitive brain potentials. Neuroscience Letters, 255(3), 163–166.

    Article  PubMed  Google Scholar 

  66. Ulusoy, M., Sahin, N. H., & Erkmen, H. (1998). Turkish version of the beck anxiety inventory psychometric properties. Journal of Cognitive Psychotherapy: An International Quarterly, 12, 163–172.

    Google Scholar 

  67. Uveges, J. M., Parker, J. C., Smarr, K. L., McGowan, J. F., Lyon, M. G., Irvin, W. S., et al. (1990). Psychological symptoms in primary fibromyalgia syndrome relationship to pain, life stress and sleep disturbance. Arthritis and Rheumatism, 33(8), 1278–1283.

    Google Scholar 

  68. Vernon, D., Egner, T., Cooper, N., Compton, T., Neilands, C., Sheri, A., et al. (2003). The effect of training distinct neurofeedback protocols on aspects of cognitive performance. International Journal of Psychophysiology, 47(1), 75–85.

    Article  PubMed  Google Scholar 

  69. Wenck, L. S., Leu, P. W., & D’Amato, R. C. (1996). Evaluating the efficacy of a biofeedback intervention to reduce children’s anxiety. Journal of Clinical Psychology, 52(4), 469–473.

    Article  PubMed  Google Scholar 

  70. Williams, D. A., & Clauw, D. J. (2009). Understanding fibromyalgia: Lessons from the broader pain research community. The Journal of Pain: Official Journal of the American Pain Society, 10(8), 777–791.

    Google Scholar 

  71. Wissel, J., Ebersbach, G., Gutjahr, L., & Dahlke, F. (1989). Treating chronic hemiparesis with modified biofeedback. Archives of Physical Medicine and Rehabilitation, 70(8), 612–617.

    PubMed  Google Scholar 

  72. Wolf, S. L. (1983). Electromyographic biofeedback applications to stroke patients. A critical review. Physical Therapy, 63, 1448–1459.

    PubMed  Google Scholar 

  73. Yazıcı, M. K., Demir, B., Tanrıverdi, N., Karaağaoğlu, E., & Yolaç, P. (1998). Hamilton Anksiyete Değerlendirme Ölçeği, değerlendiriciler arası güvenirlik ve geçerlik çalışması. Türk Psikiyatri Dergisi, 9, 114–117.

    Google Scholar 

  74. Yip, S. L., & Ng, G. Y. (2006). Biofeedback supplementation to physiotherapy exercise programme for rehabilitation of patellofemoral pain syndrome: A randomized controlled pilot study. Clinical Rehabilitation, 20(12), 1050–1057.

    Article  PubMed  Google Scholar 

  75. Yunus, M. B. (2007). Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Practice and Research. Clinical Rheumatology, 21(3), 481–497.

    Article  PubMed  Google Scholar 

  76. Yunus, M. B., Ahles, T. A., Aldag, J. C., & Masi, A. T. (1991). Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis and Rheumatism, 34(1), 15–25.

    Article  PubMed  Google Scholar 

  77. Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. The Journal of Rheumatology, 19(1), 90–94.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Erbil Dursun.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kayıran, S., Dursun, E., Dursun, N. et al. Neurofeedback Intervention in Fibromyalgia Syndrome; a Randomized, Controlled, Rater Blind Clinical Trial. Appl Psychophysiol Biofeedback 35, 293–302 (2010). https://doi.org/10.1007/s10484-010-9135-9

Download citation

Keywords

  • Fibromyalgia syndrome
  • Neurofeedback
  • Escitalopram